Chronic health impairment due to 2,3,7,8-tetrachloro-dibenzo-p-dioxin exposure

Neuroendocrinology Letters

Volumn 30, Issue SUPPL.1, 2009, Pages 219-224

  Pelclova, Daniela ^a   Fenclova, Zdenka ^a   Urban, Pavel ^a   Ridzon, Petr ^a   Preiss, Jan ^a   Kupka, Karel ^a   Malik, Jan ^a   Dubska, Zora ^a   Navratil, Tomas ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

2,3,7,8 TCDD; Diabetes; Dioxin; Neuropathy; Neuropsychological test; SPECT; Testosterone; Toxic dyschromatopsia; TSH; Vascular media

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 2,4,5 TRICHLOROPHENOXYACETIC ACID; ANTIDEPRESSANT AGENT; CARBOHYDRATE DEFICIENT TRANSFERRIN; TESTOSTERONE; THYROTROPIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; ATTENTION; CAROTID ARTERY DISEASE; CHLORACNE; CHRONIC DISEASE; CLINICAL ARTICLE; COLOR VISION DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; ELECTROENCEPHALOGRAM; EVOKED VISUAL RESPONSE; EYE EXAMINATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOLIPEMIA; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MALE; MEMORY; MENTAL DISEASE; NERVE CONDUCTION; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; OCCUPATIONAL EXPOSURE; PSYCHOMOTOR ACTIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VISUAL IMPAIRMENT;

EID: 77349097329     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Arzuaga X, Reiterer G, Majkova Z, Kilgore MW, Toborek M, Hennig B (2007). PPAR alpha ligands reduce PCB-induced endothelial activation: Possible interactions in inflammation and atherosclerosis. Cardiovasc Toxicol. 7: 264-272.
2. Beck AT, Steer RA, Brown GK (1996). BDI-II. Manual. The Psychological Corporation.
3. Benton AL, Hamsher K, Sivan AB (1983). Multilingual aphasia examination. 3rd ed. Iowa City: UIA. AJA Associates.
4. Cifková R, Skodova Z, Lanska V, Adamkova V, Novozamska E, Jozifova M, et al (2004). Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study. J Hum Hypertens. 18: 571-579.
5. Holaj R, Spacil J, Petrasek J, Malik J, Haas T, Aschermann M (2003). Intima-media thickness of the common carotid artery is the significant predictor of angiographically proven coronary artery disease. Can J Cardiol. 19: 670-676.
6. Hribek M, Krajci L, Klein J, Novosad T, Stepankova Ch (2003). The incidence of atherogenesis risk factors in officers at the ministry of defence and at the Czech army general staff (1991-2001), in Czech. Vojen Zdrav Listy. 5: 213-216.
7. IARC (1997). Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. IARC Monographs, 69. Lyon, France: International Agency for Research on Cancer.
8. Josse MO, Touboul PJ, Mas JL, Laplane D, Bousser MG (1987). Prevalence of asymptomatic internal artery stenosis. Neuroepidemiology. 6: 150-152.
9. Jung JE, Moon JY, Ghil SH, Yoo BS (2009). 2,3,7,8-Tetrachlorodibenzo- p-dioxin (TCDD) inhibits neurite outgrowth in differentiating human SH-SY5Y neuroblastoma cells. Toxicol Lett. 188: 153-156.
10. Kim YH, Shim YJ, Shin YJ, Sul D, Lee E, Min BH (2009). 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces calcium influx through T-type calcium channel and enhances lysosomal exocytosis and insulin secretion in INS-1 cells. Int J Toxicol. 28: 151-161.
11. Kopf PG, Huwe JK, Walker MK (2008). Hypertension, Cardiac Hypertrophy, and Impaired Vascular Relaxation Induced by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin are Associated with Increased Superoxide. Cardiovasc Toxicol. 8: 181-193.
12. Kovarova J, Svobodova Z (2008). Perfluorinated compounds: occurrence and risk profile. Neuroendocrinol Lett. 29: 599-608.
13. Krcmery V, Kalavsky E (2007). Antibiotic and antifungal resistance in antibiotic "free" environment? Neuroendocrinol Lett. 28 Suppl 3: 33-4.
14. Matthews J, Wilhen B, Thomsen J, Gustaffson JA (c2005). Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. Mol Cell Biol. 25: 5317-5328.
15. Nishiumi S, Yabushita Y, Furuyashiki T, Fukuda I, Ashida H (2008). Involvement of SREBPs in 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced disruption of lipid metabolism in male guinea pig. Toxicol Appl Pharmacol. 229: 281-289.
16. Pelclova D, Fenclova Z, Dlaskova Z, Urban P, Lukas E, Prochazka B, et al (2001). Biochemical, neuropsychological, and neurological abnormalities following 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure. Arch Environ Health. 56: 493-500.
17. Pelclova D, Fenclova Z, Preiss J, Prochazka B, Spacil J, Dubska Z, et al (2002). Lipid metabolism and neuropsychological follow-up study of workers exposed to 2,3,7,8-TCDD. Int Arch Occup Environ Health. 75 Suppl: 60-66.
18. Pelclova D, Prazny M, Skrha J, Fenclova Z, Kalousova M, Urban P, et al (2007). Vascular dysfunction induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Hum Exp Toxicol. 26: 705-713.
19. Pollack AL, Brodie SE (1998). Diagnostic yield of the routine dilated fundus examination. Ophthalmology 2: 382-386.
20. Portier CJ (2002). Endocrine dismodulation and cancer. Neuroendocrinol Lett. 23: 43-47.
21. Reitan RM, Wolfson D (1993). The Halstead-Reitan Neuropsychological Test Battery. Theory and clinical interpretation. 2nd ed. Tucson: Neuropsychology Press.
22. Rumak VS, Khanh TQ, Kuznetsov AN, Sofronov GA, Pavlov DS (2009). The effect of dioxins on the environment and human health. Herald Russian Acad Sci. 79: 50-56.
23. Sofronov GA, Rumak VS, Epifantsev AV (2002). Ecotoxicants and population health (In Russian). Vestn Ross Akad Med Nauk. 11: 24-28.
24. Treverry M, Crosson B, DeBoe J, Leber W (1994). The Stroop Neuropsychological Test Screening Test Manual. Psychological Assessment Resources. Odessa: FL.
25. Urban P, Pelclova D, Lukas E, Kupka K, Preiss J, Fenclova Z, et al (2007). Neurological and neurophysiological follow-up of workers with chronic poisoning by 2,3,7,8-TCDD - 35 years after exposure. Eur J Neurol. 14: 213-218.
26. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey MB, et al (1983). Development and validation of geriatric depression scale. J Psychiat Res. 17: 37-49.
27. Van den Berg M, Birnbaum L, Bosveld ATC, et al (1998). Toxic Equivalency Factors for PCBs, PCDDs and PCDFs for human and wildlife. Environ Health Persp. 106: 775-792.
28. Verriest G (1963). Further studies on acquired deficiency of color discrimination. J Opt Soc Am. 53: 185-195.
29. Vrablik M, Stulc T (2003) Hyperlipoproteinimia in higher age - un underestimated risk? (In Czech). Kardioforum. 3: 37-39.
30. Wechsler D (1945). A standardized memory scale for clinical use. J Psychol. 19: 87-95.
31. Wechsler D (1981). Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation.